Continuous versus intermittent phototherapy in treatment of neonatal jaundice: a randomized controlled trial.
Demirel HN, Ozumut SS, Ovalı HF.
Eur J Pediatr. 2024 Aug;183(8):3389-3396. doi: 10.1007/s00431-024-05610-7. Epub 2024 May 20.
Neonatal jaundice.
Maisels MJ.
Pediatr Rev. 2006 Dec;27(12):443-54. doi: 10.1542/pir.27-12-443.
Haemolytic and nonhaemolytic neonatal jaundice have different risk factor profiles.
Lee BK, Le Ray I, Sun JY, Wikman A, Reilly M, Johansson S.
Acta Paediatr. 2016 Dec;105(12):1444-1450. doi: 10.1111/apa.13470. Epub 2016 Jun 6.
[Remote monitoring of neonatal jaundice in newborns with ABO hemolytic disease].
Xu C, Bao Y, Zhu J, Teng Y, He Y, Cheng K, Ji F, Wu M.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Oct 25;49(5):651-655. doi: 10.3785/j.issn.1008-9292.2020.08.08.
Neonatal jaundice in Asia.
Ho NK.
Baillieres Clin Haematol. 1992 Jan;5(1):131-42. doi: 10.1016/s0950-3536(11)80038-7.
Hematological profile in neonatal jaundice.
Mishra JP, Mishra J, Padhi RK, Mishra S, Manjareeka M.
J Basic Clin Physiol Pharmacol. 2014 May 1;25(2):225-8. doi: 10.1515/jbcpp-2013-0087.
Early Prediction of ABO HDN Using Immuno-Hematological and Biochemical Tests.
Patale D, Sharma J, Modi C, Bhagwat S.
Maedica (Bucur). 2024 Dec;19(4):711-717. doi: 10.26574/maedica.2024.19.4.711.
Hemolytic disease in fetuses and newborns due to antibodies against the M-antigen.
Páez M, Jiménez M, Corredor A.
Biomedica. 2021 Dec 15;41(4):643-650. doi: 10.7705/biomedica.5930.
Determinants of neonatal jaundice in Ethiopia: a systematic review and meta-analysis.
Belay HG, Debebe GA, Ayele AD, Kassa BG, Mihretie GN, Worke MD.
World J Pediatr. 2022 Nov;18(11):725-733. doi: 10.1007/s12519-022-00597-3. Epub 2022 Sep 16.
Neonatal jaundice due to ABO incompatibility in Sri Lankan.
Lucas GN.
Indian J Pediatr. 1996 May-Jun;63(3):381-4. doi: 10.1007/BF02751534.
